Key result
Immunosuppressive therapy yields variable clinical courses in PPCM with biopsy-proven myocarditis.
Why the study?
Peripartum cardiomyopathy is a rare disorder in Europe with a variable clinical course and limited data on its diagnosis and management.
Case Report (n=3)
Answers are grounded in this paper and cite their sources.
Variable courses despite immunosuppression in peripartum cardiomyopathy with myocarditis; leaves open optimal therapy and need for prospective data.
BACKGROUND: In Europe, peripartum cardiomyopathy (PPCM) is a rare disorder, often difficult to diagnose and it has a variable clinical course. The aim of this report was to describe and discuss the individual variability of this disorder and its management. PATIENTS AND METHODS: Three cases of PPCM manifesting as severe heart failure are compared. Common was the presence of myocardial inflammation detected by endomyocardial biopsy. Different were treatment methods and clinical course. Modern therapeutic concepts such as immunosuppressive therapy and bromocriptin administration are discussed, as well as non-pharmacological approaches. CONCLUSION: In the differential diagnostics of dyspnea associated with pregnancy and childbirth, PPCM should be considered. The potentially severe course of the disease requires hospitalization with the possibility of comprehensive heart failure treatment, including non-pharmacological approaches such as device therapy and heart transplantation.
No takes yet. Share an insight, caveat, or question.
Krejčí et al. (2012) conducted a case report in Peripartum cardiomyopathy (n=3). Immunosuppressive therapy and/or standard heart failure treatment was evaluated. In three cases of peripartum cardiomyopathy with biopsy-proven myocarditis, clinical courses varied significantly despite treatments including immunosuppression and standard heart failure therapy.
Synapse has enriched 10 related papers. Consider them for comparative context: